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Abstract. 
 
Cell interaction with adhesive proteins or 
growth factors in the extracellular matrix initiates Ras/
mitogen-activated protein (MAP) kinase signaling. Evi-
dence is provided that MAP kinase (ERK1 and ERK2) 
influences the cells’ motility machinery by phosphory-
lating and, thereby, enhancing myosin light chain ki-
nase (MLCK) activity leading to phosphorylation of 
myosin light chains (MLC). Inhibition of MAP kinase 
activity causes decreased MLCK function, MLC phos-
phorylation, and cell migration on extracellular matrix 
proteins. In contrast, expression of mutationally active 
MAP kinase kinase causes activation of MAP kinase 
leading to phosphorylation of MLCK and MLC and en-
hanced cell migration. In vitro results support these 
findings since ERK-phosphorylated MLCK has an in-
creased capacity to phosphorylate MLC and shows in-
creased sensitivity to calmodulin. Thus, we define a sig-
naling pathway directly downstream of MAP kinase, 
influencing cell migration on the extracellular matrix.
 
C
 
ell
 
 adhesion/migration on the extracellular matrix
plays a critical role in angiogenesis, inflammatory
conditions, embryonic development, wound re-
pair, and tumor metastasis (Yang et al., 1993; Brooks et al.,
1994; Drake et al., 1995; Filardo et al., 1995; Brooks et al.,
1996; Clark et al., 1996). Integrin-mediated cellular adhe-
sion to the extracellular matrix leads to intracellular sig-
naling, including activation of focal adhesion kinase with
subsequent activation of downstream effector molecules
including mitogen-activated protein (MAP)
 
1
 
 kinases ERK1
and ERK2 (Q. Chen et al., 1994; Schlaepfer et al., 1994;
Zhu and Assoian, 1995). Activation of the MAP kinase path-
way leads to transcriptional control of genes important for
cell proliferation and differentiation (for reviews see Hill
and Treisman, 1995; Marshall, 1995). However, both growth
factor receptors and integrins promote signaling events
leading to MAP kinase activity and the immediate induc-
tion of cell migration (Stoker and Gherardi, 1991; Leaves-
ley et al., 1993; P. Chen et al., 1994; Klemke et al., 1994;
Kundra et al., 1994; Yenush et al., 1994), suggesting that
MAP kinase can lead to direct activation of the intracellu-
lar motility machinery independent of de novo gene tran-
scription.
Ultimately, the motogenic signals generated by integrin
or cytokine receptors impact the actin-myosin cytoskele-
ton and the temporal–spatial organization of cell adhesion
contacts on the extracellular matrix, as these events are
critical for cell movement (for reviews see Tan et al., 1992;
Felsenfeld et al., 1996; Huttenlocher et al., 1996; Lauffen-
burger and Horwitz, 1996; Mitchison and Cramer, 1996).
Myosins are actin-activated ATPases capable of generat-
ing force by promoting translational movement along ac-
tin cables (Sellers and Adelstein, 1987). While several
classes of myosins have been identified, myosin II is the
best characterized for its ability to promote cell contrac-
tion and migration in nonmuscle cells (McKenna et al.,
1989; Giuliano and Taylor, 1990; Wilson et al., 1991; Giu-
liano et al., 1992; Kolega and Taylor, 1993; Jay et al., 1995).
Members of this family consist of two heavy chains (200 kD)
and two sets of light chains (16–20 kD) and are widely dis-
tributed in eukaryotic cells. Myosin II is concentrated at
posterior regions of motile cells and along actin stress fi-
bers in the leading lamellae, where it is thought to play a
role in cell contraction and/or in breaking adhesion con-
tacts to the extracellular matrix (Conrad et al., 1993; Gough
and Taylor, 1993; Kolega and Taylor, 1993). Myosin II func-
tion is regulated by phosphorylation of the regulatory light
chains by the Ca
 
2
 
1
 
/calmodulin-dependent enzyme myosin
light chain kinase (MLCK) (Adelstein, 1983; de Lanerolle
and Paul, 1991). Phosphorylation of myosin light chains
(MLC) by MLCK is a critical regulatory step in myosin
function since it promotes myosin ATPase activity and po-
lymerization of actin cables. This results in a fully func-
tional actin-myosin motor unit involved in generating con-
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Abbreviations used in this paper
 
: HA, influenza hemagglutinin epitope;
MAP, mitogen-activated protein; MBP, myelin basic protein; MLC, myo-
sin light chain(s); MLCK, myosin light chain kinase.
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tractile force necessary for cell motility. While it is clear
these events are necessary for directional cell movement
(Adelstein 1983; Wilson et al., 1991; Jay et al., 1995; Smith
et al., 1996), little is known about signaling components
that result in the activation of MLCK and myosin-medi-
ated cell motility.
In this report, we investigated the role that Ras/MAP ki-
nase activation plays in regulating integrin-mediated cell
migration. We show here that MAP kinase activation is re-
quired for haptotaxis cell migration on a collagen sub-
strate based on its ability to directly phosphorylate MLCK
leading to the phosphorylation of MLC. Thus, a signaling
pathway can be defined that is initiated upon cell interac-
tion with the extracellular matrix and culminates in cell
migration.
 
Materials and Methods
 
Cell Culture
 
FG carcinoma cells were grown in RPMI 1640 (GIBCO BRL, Gaithers-
burg, MD) supplemented with 10% FBS, 50 
 
m
 
g/ml gentamicin and were free
from mycoplasma during these studies. These cells have been character-
ized with respect to their collagen-dependent migration properties (Klemke
et al., 1994). COS-7 cells were provided by Gary Bokoch (The Scripps Re-
search Institute, La Jolla, CA) and were grown in DME with 10% FBS and
50 
 
m
 
g/ml gentamicin. Before testing, all cells were starved for 24 h by re-
placing serum containing culture media with FBS-free media.
 
Antibodies and Reagents
 
Antiactin monoclonal antibodies were purchased from Sigma Chemical
Co. (St. Louis, MO). Rabbit polyclonal antibodies to MAP kinase (ERK1
and ERK2), MEK1, and RAF-1 were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). Anti–myosin IIB antibodies were kindly
provided by Dr. Robert Adelstein (Molecular Cardiology, National
Heart, Lung and Blood Institute, National Institutes of Health, Bethesda,
MD). Anti-MLCK antibodies have been previously described (de Laner-
olle et al., 1981). Antibodies to the influenza hemagglutinin epitope (HA)
were purchased from Boehringer Mannheim Corp. (Indianapolis, IN). Anti-
phosphotyrosine monoclonal antibody (4G10) was from Upstate Biotech-
nology, Inc. (Lake Placid, NY). Goat anti–rabbit and –mouse immunoglobu-
lin antibodies were from BioRad Labs (Hercules, CA). PD98059 (2-[2
 
9
 
-amino-
3
 
9
 
methoxyphenyl]-oxanaphthalen-4-one) is a compound that specifically
inhibits MEK and was graciously provided by Dr. Alan Saltiel (Parke-
Davis, Ann Arbor, MI). A stock concentration (10 mM) of this compound
was prepared in DMSO and frozen at 
 
2
 
70
 
8
 
C. The MLCK inhibitor
KT5926 was purchased from Calbiochem (La Jolla, CA). Human recom-
binant EGF was obtained from Genzyme Corp. (Cambridge, MA). Mye-
lin basic protein (MBP) was from Upstate Biotechnology, Inc.
 
Adhesive Ligands
 
Vitronectin was prepared as described by Yatohgo et al. (1988). Fibronec-
tin and collagen type 1 were obtained from Upstate Biotechnology, Inc.
 
Transfection of COS-7 Cells
 
COS-7 cells (0.5 
 
3
 
 10
 
6
 
 cells/10-cm plate) were cotransfected using 25 
 
m
 
l of
lipofectamine (GIBCO BRL) and 2 
 
m
 
g of either the eukaryotic expression
vector alone (pcDNA3; InVitrogen, San Diego, CA) or the same vector
containing the cDNA encoding the mutationally active MEK1 (MEK
 
1
 
)
along with 0.5 
 
m
 
g of a reporter construct encoding 
 
b
 
-galactosidase (pSV–
 
b
 
-galactosidase, Promega Corp., Madison, WI). Cells were also trans-
fected with either a myc-tagged ERK1 or HA-tagged ERK2 reporter con-
struct (pSR
 
a
 
) (Minden et al., 1995). In other experiments, COS-7 cells
were transfected with 0.5 
 
m
 
g of MEK
 
1
 
 cDNA and 1.5 
 
m
 
g of pCMV5 vec-
tor and/or the same vector containing mutationally inactive rabbit MLCK,
which was generated by oligonucleotide-directed mutagenesis as previ-
ously described and shown to lack enzyme activity even though it bound
calmodulin (Gallagher et al., 1991). The mutant and wild-type MLCK
calmodulin binding and kinase activity assays in COS cell lysates were
performed as previously described (Herring et al., 1992; Gallagher et al.,
1993). Cells were washed and allowed to incubate for 40 h, which provides
optimal transient expression in these cells, and then either prepared for
cell migration or lysed and analyzed for expression and phosphorylation
of specific proteins as described below. In typical transfection experi-
ments, we achieved a 40% expression efficiency providing a 30–50-fold in-
crease in the level of MEK or MLCK levels compared to endogenous
COS cell enzyme levels as determined by Western blotting. Cells cotrans-
fected with 
 
b
 
-galactosidase were developed using X-gal as a substrate ac-
cording to the manufacturer’s recommendations (Promega Corp.). In
some cases, cells were treated with EGF (100 ng/ml) or different doses of
the MEK inhibitor PD98059 and/or the MLCK inhibitor KT5926 for vari-
ous times before cell migration or protein analysis.
 
Cell Adhesion and Haptotaxis Migration Assays
 
Cell adhesion and spreading was performed on collagen-coated surfaces
as previously described (Leavesley et al., 1992). Briefly, cell migration as-
says were performed using modified Boyden chambers (tissue culture–
treated, 6.5-mm diameter, 10-
 
m
 
m thickness, 8-
 
m
 
m pores, Transwell
 
®
 
; Cos-
tar Corp., Cambridge, MA) containing polycarbonate membranes. The
underside of the membrane of the upper chamber was coated with 10 
 
m
 
g/ml
collagen type I (Upstate Biotechnology Inc.) for 2 h at 37
 
8
 
C, rinsed once
with PBS, and then placed into the lower chamber containing 500 
 
m
 
l mi-
gration buffer (fibroblast basal medium, with 0.5% BSA, Clonetics, San
Diego, CA). Serum-starved cells were removed from culture dishes with
Hanks’ balanced salt solution containing 5 mM EDTA and 25 mM Hepes,
pH 7.2, washed twice with migration buffer, and then resuspended in fi-
broblast basal medium, 0.5% BSA (10
 
6
 
 cells/ml). 50,000–100,000 cells
were then added to the top of each migration chamber and allowed to mi-
grate to the underside of the top chamber for various times. Nonmigratory
cells on the upper membrane surface were removed with a cotton swab,
and the migratory cells attached to the bottom surface of the membrane
were stained with X-gal substrate as described above (for 
 
b
 
-galactosidase–
expressing cells) or 0.1% crystal violet in 0.1 M borate, pH 9.0, and 2%
ethanol for 20 min at room temperature. The number of migratory cells
per membrane were either counted with an inverted microscope using a
40
 
3
 
 objective, or the stain was eluted with 10% acetic acid and the absor-
bance was determined at 600 nm, and migration was enumerated from a
standard curve. Each determination represents the average of three indi-
vidual wells, and error bars represent SD. All values have had background
subtracted, which represents cell migration on membranes coated on the
bottom with BSA (1%). In control experiments, cell migration on BSA
was 
 
,
 
0.01% of the total cell population.
 
Immunoprecipitation and Immunoblotting of ERK and 
MEK Proteins
 
Cells were rinsed twice with PBS and then lysed with RIPA buffer (100
mM Tris, 0.15 M NaCl, 1% deoxycholic acid, 1% Triton X-100, 0.1% SDS,
1% aprotinin, 2 mM PMSF, 10 
 
m
 
g/ml leupeptin, 5 mM EDTA, 1 mM so-
dium vanadate, and 50 mM NaF) for 1 h at 4
 
8
 
C. The lysate was clarified by
centrifugation at 14,000 rpm for 10 min, and the amount of total protein
was determined using the BCA protein assay reagent (Pierce, Rockford,
IL). The protein concentration of the samples were normalized before ei-
ther direct immunoblotting of total cell proteins or immunoprecipitation
of equivalent amounts of proteins with ERK antibodies bound to protein
A–Sepharose beads. Samples were analyzed by SDS-PAGE and then
transferred to nitrocellulose and blocked with BSA (3%, Sigma Chemical
Co.) before immunoblot analysis using antiphosphotyrosine monoclonal
antibody (4G10) or anti-MEK and horseradish peroxidase–conjugated goat
anti–mouse or rabbit secondary antibodies and the enhanced chemilumi-
nescence system. In some cases, the immunoblots were stripped and re-
probed with antibodies according to the manufacturer’s recommendations
(enhanced chemiluminescence, Amersham Corp., Arlington Heights, IL).
 
Treatment of Cells with ERK Oligonucleotides
 
Depletion of MAP kinase (ERK1 and ERK2) from cells was performed
according to the procedure of Sale et al. (1995) with minor modifications.
Briefly, FG cells grown to 60% confluency in 60-mm tissue culture dishes
were incubated in culture media containing lipofectamine (40 
 
m
 
g/ml) and
1.5 
 
m
 
M ERK antisense (5
 
9
 
-GCC GCC GCC GCC GCC AT-3
 
9
 
; Genset) or
control phosphorothioate oligonucleotides (5
 
9
 
-CGC GCG CTC GCG 
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CAC CC-3
 
9
 
) for 8 h at 37
 
8
 
C. They were then rinsed, incubated for 16 h in
fresh culture medium containing oligonucleotides, starved for 16 h in se-
rum-free culture media containing oligonucleotides, and then tested in ad-
hesion and migration assays as described above. An aliquot of the above
cells was analyzed in parallel with cell migration assays for changes in
ERK protein levels using the ERK-specific antibodies and Western blot-
ting as described above. As a control for nonspecific depletion of proteins,
the blots were stained with Ponceau dye to visualize total cellular proteins
and then stripped and reprobed with antiactin, anti-MEK, and anti–Raf-1
antibodies.
 
In Vitro Kinase Assay for MAP Kinase
 
The ability of ERK to phosphorylate MBP was determined according to
Boulton and Cobb (1991). Briefly, 500 
 
m
 
g of protein from detergent cell
lysates were precleared with protein A–Sepharose for 4 h in the cold and
then incubated with protein A–Sepharose coupled with anti-ERK anti-
bodies (4 
 
m
 
g/100 
 
m
 
l stock bead suspension; Pierce) overnight in the cold.
Immunoprecipitates were rinsed three times with RIPA and once with 50
mM Hepes, pH 8.0, containing 0.1 M NaCl before incubation with 100 
 
m
 
l
of reaction mixture containing 0.5 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP, 10 mM MgCl, 50 
 
m
 
M
ATP, 1 mM DTT, 1 mM benzamidine, 0.3 mg/ml MBP, and 25 mM Hepes,
pH 8.0, for 15 min at 30
 
8
 
C. The reaction was stopped by adding 100 
 
m
 
l of
boiling SDS sample buffer. MBP (8 
 
m
 
g) was then analyzed by 15% SDS-
PAGE, stained with Coomassie blue, dried, and exposed to imaging film
overnight.
 
32
 
P Labeling and Immunoprecipitation of Myosin and 
MLCK from COS-7 Cells
 
Preparation of cell lysates and immunoprecipitation of myosin were per-
formed according to de Lanerolle et al. (1993). Briefly, COS-7 cells co-
transfected as described above with either empty vector or the MEK
 
1
 
vector together with the HA-ERK2 reporter construct were cultured for 6 h
in phosphate-free media and then isotopically labeled with 5 ml of DME
phosphate-free media containing 250 
 
m
 
Ci/100-mm petri dish for 2 h in the
presence or absence of the MEK inhibitor PD98059 (25 
 
m
 
M) or the MLCK
inhibitor KT5926 (10 
 
m
 
M). Cells were rinsed twice with ice-cold PBS, cell
extracts were prepared, and the protein concentration was determined as
described above. Total cell proteins (20–50 
 
m
 
g) were either analyzed di-
rectly for changes in phosphoproteins by SDS-PAGE and autoradiogra-
phy or immunoprecipitated and Western blotted with anti–myosin IIB or
MLCK-specific antibodies before autoradiography. Alternatively, myosin
or MLCK was immunoprecipitated from these extracts (750 
 
m
 
g protein/
IP) and analyzed for changes in phosphorylation by SDS-PAGE and auto-
radiography.
 
In Vitro Phosphorylation of MLCK by Activated MAP 
Kinase (ERK1)
 
Purified chicken gizzard MLCK (4.2 
 
m
 
g) was incubated at 30
 
8
 
C in the
presence or absence (control for autophosphorylation of MLCK) of 0.4 
 
m
 
g
of purified activated ERK1 or ERK2 (a kind gift from Drs. D. Schlaepher
and T. Hunter, Salk Institute, La Jolla, CA) in 50 
 
m
 
l of kinase reaction
mixture (10 mM MgCl
 
2
 
, 2 mM DTT, 0.5 mM Na
 
3
 
VO
 
4
 
, 5 mM NaF, 20 mM
Tris, pH 7.5, and 0.1 mM ATP (1 mCi/ml). Aliquots that contained 1 
 
m
 
g of
MLCK were removed at 5, 10, 20, and 40 min, boiled in SDS sample buf-
fer, separated by SDS-PAGE, and then stained with Coomassie blue and
analyzed by autoradiography.
 
In Vitro Phosphorylation of MLC by MLCK Previously 
Phosphorylated by MAP Kinase (ERK1)
 
Phosphorylation of myosin II by MLCK was performed as previously de-
scribed by de Lanerolle and Nishikawa (1988). Briefly, MLCK (50 ng) was
either phosphorylated or not phosphorylated with activated MAP kinase
(ERK1) as described above and then incubated with 10 
 
m
 
g of myosin II
purified from macrophage-like J774 cells in 50 
 
m
 
l of reaction buffer (10 mM
MgCl
 
2
 
, 0.5 mM ATP [1 mCi/ml], 20 mM Tris, pH 7.5) in the presence or
absence of 0.5 mM EGTA or 0.4 mM calcium and 10
 
2
 
6
 
 M calmodulin. The
kinase reactions were performed at room temperature for various times,
terminated by boiling in SDS, and analyzed by SDS-PAGE and autora-
diography.
Purified MLC were phosphorylated as described above except 10 
 
m
 
g of
MLC purified from chicken gizzard smooth muscle was used as substrate.
Aliquots of the reaction mixture containing 2 
 
m
 
g of light chain were re-
moved, boiled in SDS, and analyzed by SDS-PAGE and autoradiography.
Importantly, the ability of activated MAP kinase to phosphorylate MLC
was tested by repeating the assay under identical conditions using 5 ng of
activated MAP kinase, which is the amount calculated to be present in the
MLCK assays following phosphorylation by MAP kinase. The effect of
calmodulin on MLC phosphorylation was determined by adding 0.4 mM
calcium and various concentrations of calmodulin to the assay mixtures.
 
Results
 
MAP Kinase Is Critical for Cell Migration but Not 
Adhesion or Spreading on Collagen
 
To examine a potential role of MAP kinase in cell migra-
tion, we examined FG carcinoma cells, which readily mi-
grate on a collagen substrate using integrin 
 
a
 
2
 
b
 
1 (Leavesley
et al., 1992; Klemke et al., 1994). FG cells were pretreated
with antisense oligonucleotides specific for ERK1 and ERK2
(Sale et al., 1995) or a scrambled control oligonucleotide
and allowed to attach, spread, and migrate on a collagen
substrate. As shown in Fig. 1 
 
A
 
, 
 
upper panel
 
, exposure of
cells to antisense but not a control oligonucleotide reduced
ERK1 and ERK2 protein levels by 
 
z
 
90% yet had no ef-
fect on expression of other proteins in these cells, as deter-
mined by Western blotting with antibodies to Raf-1 and
actin or a nonspecific protein recognized by the rabbit poly-
clonal antibodies to ERK1 and ERK2. Cells treated with
the antisense oligonucleotide readily attached and spread
(data not shown) on collagen, but showed 75% decreased
migration (Fig. 1 
 
A
 
, 
 
lower panel
 
) relative to cells treated with
the control oligonucleotide. These findings suggest that
MAP kinase influences cell migration yet has little apparent
effect on adhesion or spreading on a collagen substrate.
ERK1 and ERK2 are specifically activated by MAP ki-
nase kinase (MEK1) because of its ability to promote both
threonine and tyrosine phosphorylation of these enzymes
(Cowley et al., 1994; Mansour et al., 1994; Zheng and
Guan, 1994). Therefore, cells were pretreated with an in-
hibitor of MEK (PD98059), which specifically prevents its
ability to promote both threonine and tyrosine phosphory-
lation of MAP kinase (Dudley et al., 1995; Pang et al., 1995),
and allowed to attach, spread, or migrate on collagen. Pre-
treatment of the cells with the MEK inhibitor blocked ERK1
and ERK2 phosphorylation induced by FG cell attach-
ment to collagen in the absence of growth factors as mea-
sured by both immunoblotting with antiphosphotyrosine
antibody and phosphorylation of the ERK substrate, MBP
(Fig. 1 
 
B
 
, 
 
upper panel
 
). Inhibition of MEK activity in these
cells dramatically reduced their migration (Fig. 1 
 
B
 
, 
 
lower
panel
 
) yet had no effect on cell attachment or spreading
(Fig. 1 
 
C
 
), even after 6 h of exposure to the MEK inhibi-
tor. FG cells can be stimulated to migrate with cytokines
(Klemke et al., 1994). Treatment of these cells with the
MEK1 inhibitor blocked the EGF-induced migration of
these cells and selectively prevented EGF-induced ERK1
and ERK2 phosphorylation without impacting other EGF-
dependent phosphorylation events, including the auto-
phosphorylation of the EGF receptor (data not shown).
Together, these findings implicate MAP kinase in the cell
migration response induced by integrin and/or cytokine
receptor ligation. Importantly, MAP kinase activity is ap-
parently not required for cell adhesion or spreading. 
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Figure 1. MAP kinase (ERK1
and ERK2) is required for cell
migration but not adhesion
or spreading on extracellular
matrix proteins. (A, lower
panel) Cells were allowed to
adhere for 1 h or migrate for
6 h on a collagen substrate
after exposure to MAP ki-
nase–specific antisense or a
scrambled control oligonu-
cleotide. Migration studies
were performed using Tran-
swell migration chambers
coated with collagen as de-
scribed in Materials and Meth-
ods. (Upper panel) Total cell
lysates (50 mg) prepared from
an aliquot of those FG cells
analyzed for migration/adhe-
sion were immunoblotted with
antibodies to Raf-1, actin, or
ERK proteins. The upper
band is a nonspecific protein
recognized by the rabbit poly-
clonal ERK antisera. The re-
sult shown is a representative
experiment from at least three
independent experiments. (B,
upper panel) Phosphoty-
rosine immunoblot or kinase
activity of ERK1 and ERK2
proteins immunoprecipitated
from cells either pretreated in
the presence or absence of
the MEK inhibitor PD98059
(25 mM) and allowed to at-
tach to poly-l-lysine or col-
lagen-coated dishes for 30
min. The ERK immunopre-
cipitates were also examined
for their ability to phosphory-
late MBP in an in vitro kinase
assay as described in Materi-
als and Methods. (Lower
panel) Cells treated in the
presence or absence of the
MEK inhibitor as above were
allowed to attach for 1 h or
migrate for 6 h on a collagen
substrate and quantified as
described in Materials and
Methods. The result shown is
a representative experiment
from at least three indepen-
dent experiments. (C) Nomar-
ski photomicrograph (6003)
of FG cells pretreated for 6 h
in the presence or absence
(control) of the MEK inhibi-
tor (100 mM) and allowed to
attach and spread on col-
lagen-coated coverslips for
10 or 60 min. The result
shown is a representative ex-
periment from at least three
independent experiments.
Bar, 10 mm. 
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MAP Kinase Activation Regulates Cell Migration
 
To further investigate the role of MAP kinase in cell mo-
tility, we used COS-7 cells since they efficiently express
plasmids encoding members of the Ras/MAP kinase cas-
cade (Howe et al., 1992; Cowley et al., 1994; Coso et al.,
1995). Furthermore, COS-7 cells, like FG cells, migrate on
collagen using integrin 
 
a
 
2
 
b
 
1 (data not shown). In these ex-
periments, we transiently expressed a mutationally active
MEK1(MEK
 
1
 
) in COS-7 cells and examined their migra-
tory properties on a collagen substrate. As shown in Fig.
2 
 
A
 
, 
 
upper panel
 
, serum-starved MEK
 
1
 
 transfectant cells
showed a four- to fivefold increase in migration relative to
control cells transfected with the same expression vector
without the MEK1 gene. However, the relative adhesive
properties of these cells that were measured remained un-
changed (data not shown). These cells also showed en-
hanced migration on fibronectin and vitronectin (data not
shown), indicating that the mutationally active MEK1 could
stimulate the general migratory properties of these cells. This
induction of cell migration was associated with increased
MAP kinase activity as measured by antiphosphotyrosine
immunoblotting as well as increased phosphorylation of
the substrate MBP (Fig. 2 
 
A
 
, lower panel). As expected,
serum-starved cells exposed to EGF showed enhanced cell
migration and increased MAP kinase activity (Fig. 2 A)
Figure 2. Stimulation of COS-7 cell migration after transfection with mutationally activated MEK1. (A, upper panel) COS-7 cells were
serum starved for 18 h and allowed to migrate for 3 h on collagen-coated membranes after transient transfection with either the empty
expression vector (pcDNA-3, control) or the expression vector containing the mutationally activated MEK1 (MEK1) as described in
Materials and Methods. In both cases, cells were cotransfected with a b-galactosidase–containing vector (pSV–b-galactosidase) for in
situ b-galactosidase staining with X-gal and a myc-tagged ERK1 reporter construct as described in Materials and Methods. This facili-
tated enumeration of only those migratory cells that had been positively transfected. In either case, transfection efficiency was routinely
30–40%. Alternatively, control transfectants were allowed to migrate in the presence of EGF (100 ng/ml) and then enumerated by
counting cells on the underside of the migration chamber using an Olympus (BX60) inverted microscope. Cells per high-powered (403)
field were counted blindly by two observers. Each bar represents the mean 6 SD of triplicate migration wells of an independent experi-
ment. (Lower panel) Detergent lysates from cells treated as above were either directly immunoblotted for MEK protein expression using
rabbit anti-MEK or subjected to immunoprecipitation using anti-ERK followed by immunoblotting with antiphosphotyrosine as de-
scribed in Materials and Methods. In addition, these immunoprecipitates were analyzed for MAP kinase activity using an in vitro kinase
assay and the substrate MBP as described in Materials and Methods. The result shown is a representative experiment from at least three in-
dependent experiments. (B, upper panel) COS-7 cells treated as described in A were allowed to migrate in the presence or absence of
the MEK inhibitor (25 mM, PD98059) for 2–4 h and then stained and quantitated as described above. (Lower panel) Detergent lysates
from these cells were examined for expression of MEK, ERK phosphorylation, and kinase activity using MBP as a substrate as de-
scribed above.The Journal of Cell Biology, Volume 137, 1997 486
(Howe et al., 1992). Importantly, cell migration induced by
MEK1 expression was also blocked with the MEK inhibi-
tor PD98059 (Fig. 2 B, upper panel), as was activation of
ERK2 in these cells (Fig. 2 B, lower panel). These studies
demonstrate that MAP kinase signaling events are critical
for the induction of cell migration.
MAP Kinase Activation Promotes
MLC Phosphorylation
Potential mediators of cell migration downstream of MAP
kinase were identified by examining the phosphoprotein
profile from MEK1 COS-7 cells metabolically labeled with
[32P]orthophosphate. We observed in MEK1 but not con-
trol transfectants the presence of labeled proteins migrat-
ing at z20 kD that comigrated with MLC (Fig. 3 A). We
then subjected these same lysates to immunoprecipitation
using an antibody directed to myosin IIB since this form of
myosin is present in COS cells (Klemke, R., unpublished
data). This antibody precipitated the 20-kD light chains
from these cells, which showed increased phosphate incor-
poration in the MEK1 cells relative to vector transfected
control cells Fig. 3 B. In addition, the phosphorylation of
this protein was blocked by pretreatment of MEK1 cells
with the MEK inhibitor PD98059 (Fig. 3).
Phosphorylation of MLC by the Ca21/calmodulin-depen-
dent enzyme, MLCK, is critical for cell migration. This re-
action promotes increased myosin filament formation
leading to its association with actin filaments and stimu-
lates the actin-activated ATPase activity of myosin II. In
addition, the fact that MLCK contains multiple MAP ki-
nase consensus phosphorylation sites (P-x-S[T]-P) (Shoe-
maker et al., 1990) prompted us to examine the possibility
that MLCK could be directly phosphorylated by MAP ki-
nase. Therefore, MLCK was immunoprecipitated from
MEK1 or control transfectants that had been metaboli-
cally labeled with [32P]orthophosphate. As shown in Fig. 4
A, anti-MLCK antibodies precipitated radiolabeled pro-
teins of 160–200 kD, which represents isoforms of MLCK
found in COS-7 cells and an additional (z97 kD) break-
down product of MLCK as previously described (Gallagher
et al., 1995). In contrast, cells transfected with a control
vector express these proteins with minimal phosphate in-
corporation (Fig. 4 A). The phosphorylation of MLCK ap-
Figure 3. MAP kinase activity
is associated with increased
MLC phosphorylation. (A)
COS-7 cells transfected with
empty vector or MEK1 to-
gether with HA-tagged
ERK2 reporter construct
were labeled metabolically
for 2 h with [32P]orthophos-
phate in the presence or ab-
sence of the MEK inhibitor
(25 mM). Cells were then
lysed in detergent and ana-
lyzed (20 mg total cell pro-
tein) by SDS-PAGE and
autoradiography for changes
in phosphorylation as de-
scribed in Materials and
Methods. Arrows depict ex-
pected migration of HA-
ERK2 and MLC. (B) MLC or
HA-tagged ERK2 were im-
munoprecipitated from the above lysates with anti–myosin IIB or anti-HA specific antibodies, respectively, and analyzed for changes in
phosphorylation as described in Materials and Methods. The result shown is a representative experiment from at least three indepen-
dent experiments.
Figure 4. MAP kinase activ-
ity is associated with in-
creased phosphorylation of
MLCK. (A) MLCK was im-
munoprecipitated from an ali-
quot of COS-7 cell lysates de-
scribed in Fig. 3 and resolved
by SDS-PAGE and autoradi-
ography or (B) Western blot-
ted with an MLCK-specific
antibody. The phosphorylated
proteins of z160 and 200 kD
represent MLCK isoforms present in COS-7 cells, whereas the 97-kD protein may represent a break down product of MLCK. The result
shown is a representative experiment from at least three independent experiments.Klemke et al. MAP Kinase, Myosin Light Chain Kinase, Cell Migration 487
peared to be caused by the activation of MAP kinase in
these cells since MEK1 cells treated with the MEK inhibi-
tor showed a loss of the MLCK phosphorylation. The en-
hanced phosphorylation of MLCK in MEK1 cells could
not be explained by increased MLCK protein expression
since immunoblotting experiments revealed that lysates
from these and control cells contained the same level of
MLCK (Fig. 4 B).
MAP Kinase Directly Phosphorylates MLCK Leading 
to MLC Phosphorylation In Vitro
To establish whether MLCK is a direct substrate for MAP
kinase, we examined the ability of constitutively active
MAP kinase (ERK1 or ERK2) to phosphorylate purified
MLCK in an in vitro kinase assay. As shown in Fig. 5 A,
purified active MAP kinase promoted a time-dependent
increase in MLCK phosphorylation. This event could not
be attributed to MLCK autophosphorylation since, in the
absence of MAP kinase, we observed no significant phos-
phorylation of MLCK under the same reaction conditions
(Fig. 5 A). MLCK phosphorylated with ERK2 for 40 min
was then allowed to incubate with MLC in the presence or
absence of calcium/calmodulin (Fig. 5 B). In this case,
MLC phosphorylation was shown to depend on the pres-
ence of calcium/calmodulin. In addition, ERK2 in the ab-
sence of MLCK was incapable of phosphorylating MLC
(Fig. 5 B).
We then examined the ability of MLCK incubated with
ERK for either 10 or 40 min to phosphorylate MLC in an
in vitro kinase assay. As shown in Fig. 5 C, MLCK exposed
Figure 5. MAP kinase directly phosphorylates MLCK, which
leads to increased MLC phosphorylation in vitro. (A) Purified
MLCK was monitored for phosphorylation in the presence or ab-
sence of purified activated MAP kinase for various times in an in
vitro kinase assay as described in Materials and Methods. Note
that there is no detectable phosphorylation of MLCK in the ab-
sence of MAP kinase. The result shown is a representative exper-
iment from at least three independent experiments. (B) Purified
MLCK phosphorylated by MAP kinase for 40 min was tested for
its ability to phosphorylate MLC in an in vitro kinase assay in the
presence or absence of Ca/calmodulin. Note that MLC was not
phosphorylated by purified activated MAP kinase in these exper-
iments. The result shown is a representative experiment from at
least three independent experiments. (C) MAP kinase was al-
lowed to phosphorylate MLCK as described in vitro for 10 or 40
min as described in Materials and Methods. The MLCK treated
in the presence or absence of ERK was then allowed to phosphor-
ylate MLC for 4 min in the presence of calcium and calmodulin as described in Materials and Methods. Data are expressed as percent of
control MLCK activity (i.e., MLCK incubated for 10 min in the absence of ERK). Each point represents the mean 6 SE of at least three
experiments. The results are significant P , 0.005.
Figure 6. MLCK, exposed to activated ERK or buffer (control) for
40 min, was allowed to phosphorylate MLC in the presence of vary-
ing concentrations of calmodulin as described in Materials and
Methods. Data are expressed as the percent of maximal MLCK
activity (i.e., MLCK phosphorylated by ERK in the presence
of 1,000 nM calmodulin, which represents 1.5 mmol 32P/min/mg
MLCK). Each point represents the mean 6 SE of at least three
experiments.The Journal of Cell Biology, Volume 137, 1997 488
to ERK for 10 min showed little change in MLCK activity,
whereas after 40 min ERK promoted increased MLCK ac-
tivity. While the nonphosphorylated MLCK showed no
enhanced enzymatic activity over time, MLCK phosphory-
lated by MAP kinase for 40 min showed an increase in
MLCK activity by .50% (Fig. 5 C). This increased MLCK
activity was associated with an eightfold stoichiometric in-
crease in MLCK phosphorylation. In the absence of ERK,
0.05 mol of phosphate/mol was incorporated into MLCK,
whereas 0.42 mol of phosphate/mol of MLCK was incor-
porated after 40 min of exposure to activated ERK.
To further examine the change in MLCK activity after
phosphorylation by MAP kinase, MLCK was incubated in
the presence or absence of mutationally active ERK, and
the MLCK was then allowed to phosphorylate MLC in the
presence of varying concentrations of calmodulin. As shown
in Fig. 6, MLCK phosphorylated by ERK has increased
sensitivity to calmodulin over a wide range of concentrations.
Figure 7. MLCK activity is required for MAP kinase-induced phosphorylation of MLC and cell migration. (A, upper panel) COS cells
were transfected with empty vector or mutationally active MEK1 along with an HA-tagged ERK2 reporter construct. Cells were al-
lowed to migrate on a collagen substrate for 3 h in the presence or absence of the MLCK inhibitor KT5926 (10 mM) as described in
Materials and Methods. Cell migration was enumerated as described above. (Lower panel) Lysates prepared from these COS cells met-
abolically labeled with 32P were examined by SDS-PAGE and autoradiography. The position of HA-tagged ERK and MLC are denoted
by arrows. (B, upper panel) COS cells were transfected with mutationally active MEK1 and/or MLCK(Mut) and allowed to migrate on a
collagen substrate as described in Materials and Methods. Cell migration was quantified by counting the number of migrant cells per
high powered microscopic field as described above. (Lower panel) Lysates prepared from 32P metabolically labeled COS cells trans-
fected as above were examined for phosphorylation of HA-ERK and MLC. The result shown is a representative experiment from at least
three independent experiments.Klemke et al. MAP Kinase, Myosin Light Chain Kinase, Cell Migration 489
In fact, half-maximal ERK-activated MLCK required two
to threefold less calmodulin than MLCK not activated by
ERK. Together, these findings reveal that phosphoryla-
tion of MLCK by MAP kinase leads to increased MLCK
activity and a decreased requirement for calmodulin.
MAP Kinase–induced Cell Migration Requires MLCK 
Activity and MLC Phosphorylation
To establish a role for MLCK in the MAP kinase–induced
cell migration response, COS cells transfected with MEK1
were allowed to migrate in the presence or absence of the
MLCK inhibitor KT5926 (Nakanishi et al., 1990). As shown
in Fig. 7 A, upper panel, KT5926 not only blocked the MEK-
induced migration response but also prevented the phos-
phorylation of MLC in these cells in response to the ex-
pression of MEK1 (Fig. 7 A, lower panel). These findings
suggest that MLCK plays a pivotal role in the MAP ki-
nase–induced cell migration response.
To further establish that MLCK activity is required for
MAP kinase–induced cell migration, COS-7 cells express-
ing MEK1 were transfected with a mutationally inacti-
vated form of rabbit smooth muscle MLCK (MLCK[Mut])
containing a single in frame deletion at K725. Residue
K725 is predicted by alignment with other ser/thr kinases
to have a key role in binding ATP and thereby acting as a
dominant-negative enzyme (Hanks et al., 1988; Zoller et al.,
1981; Knighton et al., 1991). This recombinant enzyme ex-
pressed in COS cells has no detectable catalytic activity,
even at ATP concentrations that are 10-fold greater than the
KmATP determined for smooth muscle MLCK (Gallagher
et al., 1993). This enzyme was incapable of phosphorylat-
ing MLC in COS cells even though its calmodulin binding
capacity was identical to the wild-type enzyme (Gallagher,
P.J., unpublished results). Importantly, this mutant enzyme
expressed in COS cells not only blocked cell migration in-
duced by mutationally active MEK (Fig. 7 B, upper panel),
but it also prevented the MEK-induced MLC phosphory-
lation in these cells (Fig. 7 B, lower panel). In addition,
when EGF (100 ng/ml) was used to stimulate COS cell mi-
gration on collagen, expression of the mutant MLCK com-
pletely blocked the EGF-induced migration response (data
not shown). These results are consistent with the notion
that this mutant form of MLCK acts in a dominant-nega-
tive manner when introduced into MEK1 COS cells. It is
noteworthy that the activity of MAP kinase in the MEK1
cells was not significantly impacted by either the mutation-
ally inactive MLCK or the MLCK inhibitor KT5926 (Fig. 7),
suggesting that MLCK and MLC phosphorylation are down-
stream of MAP kinase and necessary for the migration of
these cells.
Model Depicting Role of MAP Kinase in Cell Migration
Based on the experiments described above and the work
of others, it is now possible to develop a model that depicts
the signaling pathway leading from integrin and/or growth
factor ligation to myosin activation and cell migration (Fig.
8). This model identifies a signaling pathway involving the
ability of MAP kinase to directly phosphorylate MLCK,
which in turn is better able to phosphorylate MLC. Impor-
tantly, this pathway is independent of the ability of MAP
kinase to translocate to the nucleus where it activates gene
transcriptional events involved in cell proliferation and
differentiation.
Discussion
Cellular recognition of growth factors and adhesive pro-
teins within the extracellular matrix influences whether a
cell undergoes proliferation, differentiation, or migration.
It is now clear that growth factor/cytokine receptors as
well as adhesion receptors influence the activity of one or
more members of the MAP kinase family of signaling mol-
ecules that have been implicated in a wide range of cell bi-
ological events. While MAP kinase signaling has been as-
sociated with the regulation of gene transcriptional events,
we now present evidence that MAP kinase can promote
cell migration on the extracellular matrix in a transcrip-
tion-independent manner. We propose that MAP kinase
can directly phosphorylate MLCK, thereby increasing its
ability to phosphorylate MLC, which promotes cytoskele-
tal contraction necessary for cell movement (Sellers and
Adelstein, 1987; Tan et al., 1992). While cell migration de-
pends on cell adhesion as well as deadhesion of cell surface
receptors and may be influenced by cell shape (Crowley and
Horwitz, 1995), our findings that MAP kinase induction of
MLCK activity has little or no influence on cell adhesion
or spreading suggests these events may be differentially
regulated. In fact, stress fiber formation and membrane
ruffling has been associated with activation of small G pro-
Figure 8. Model depicting role of MAP kinase in cell migration.
Proposed signaling pathway leading from integrin or growth fac-
tor receptor ligation to activation of cell migration. This model
takes into account that MAP kinase can be activated by integrins
and/or growth factors. As shown in this study, once activated,
MAP kinase can phosphorylate MLCK, which in turn shows en-
hanced activity as measured by its ability to phosphorylate MLC.
This model assumes that this phosphorylated MLC regulates the
cell’s actin-myosin motor function, thereby facilitating contrac-
tion leading to cell movement on the extracellular matrix.The Journal of Cell Biology, Volume 137, 1997 490
teins Rho, Cdc42, and rac (for reviews see Schwartz et al.,
1995; Vojteck and Cooper, 1995; Parsons, 1996), and these,
apparently, do not promote ERK1 or ERK2 activity but
have been shown to activate the MAP kinases, p38 and
JNK (Coso et al., 1995; Minden et al., 1995).
Growth factors/cytokines as well as integrins influence
MAP kinase activity and regulate the motility of various
cell types (Stoker and Gherardi, 1991; Leavesley et al.,
1993; P. Chen et al., 1994; Klemke et al., 1994; Kundra et al.,
1994; Yenush et al., 1994). Cellular transformation by H-Ras
or c-Src is also associated with increased MAP kinase activity
and enhanced cell proliferation and migration (Ochieng
et al., 1991; Rodier et al., 1995). Therefore, the mitogenic
and motogenic signals mediating these processes may be
on a common pathway leading to MAP kinase activation,
which may diverge based on the ability of MAP kinases to
translocate to distinct intracellular compartments. In fact,
activated MAP kinase has been shown to translocate to the
nucleus (Gonzalez et al., 1993; Q. Chen et al., 1994) and/or
the cytoskeleton (Gonzalez et al., 1993; Reszka et al., 1995).
In this report, we provide several lines of evidence that
MAP kinase (ERK1 and ERK2) signaling can regulate cell
migration by directly impacting the migratory machinery.
First, blocking ERK expression with antisense oligonucle-
otides or ERK activity with a selective MEK inhibitor re-
sulted in the loss of cell migration with no obvious effect
on cell adhesion on a collagen substrate. Second, a muta-
tionally active form of MEK1, when expressed in serum-
starved COS-7 cells, significantly enhanced their migra-
tory properties, which were blocked by MEK inhibition.
EGF, a known inducer of cell motility, promoted collagen-
dependent COS cell migration that was also blocked by in-
hibition of MEK (data not shown). Third, MLCK, a known
activator of MLC phosphorylation, was found to be highly
phosphorylated in cells expressing mutationally active MEK.
In fact, MLCK contains multiple MAP kinase consensus
phosphorylation sites (P-x-S[T]P) (Shoemaker et al., 1990;
Clark-Lewis et al., 1991). Importantly, ERK1 and ERK2
were able to directly phosphorylate MLCK leading to en-
hanced MLC phosphorylation in vitro. This increased ac-
tivity was associated with an increased sensitivity to cal-
cium/calmodulin. In fact, MLCK activity showed a 50%
increase in activity after exposure to ERK from 10–40 min
in vitro. Finally, the migratory properties of MEK1 cells,
containing active MAP kinase, could be blocked by selec-
tively interfering with MLCK activity, suggesting that
MLCK is downstream of MAP kinase and required for cell
migration. In support of this contention, expression of a
mutant form of MLCK that does not bind ATP functioned
as a dominant-negative mutant, thereby inhibiting the
phosphorylation of MLC and induction of cell migration
by MAP kinase. Together, these findings support the no-
tion that MAP kinase activates the cells’ motility machin-
ery by enhancing the activity of MLCK leading to in-
creased MLC function. Therefore, we define a signaling
pathway initiated from integrin and/or growth factor re-
ceptor ligation that leads to increased myosin phosphory-
lation (see proposed pathway depicted in Fig. 8).
While our results indicate a role for MAP kinase in cell
movement, other mechanisms may regulate MLC phos-
phorylation and cell motility. In fact, light chain phosphor-
ylation by Ca21/phospholipid-dependent protein kinase II,
protein kinase C, and cAMP-dependent protein kinase are
important for myosin function in vivo (for review see Tan
et al., 1992). Recent findings also indicate that rhoA in-
duces MLC phosphorylation and cell contraction leading
to FAK activation and focal contact formation (Chra-
nowska-Wodnicka and Burridge, 1996). However, it is not
yet clear whether any of these signaling events can directly
or indirectly influence cell movement. In addition, it is
possible that other MAP kinases, such as JNK or p38, once
activated, impact this or other signaling pathways leading
to cell migration. In any case, it is clear that in the cells ex-
amined, ERK1 and/or ERK2 are critical for collagen-depen-
dent cell migration. Importantly, this signaling pathway
appears to regulate cell migration on at least two other
matrix proteins, vitronectin and fibronectin, even though
it had no obvious impact on cell adhesion to each of these
proteins. Thus, it is apparent that cell adhesion and migra-
tion can be differentially regulated. Perhaps this is not sur-
prising since many adherent cell types do not migrate
without prior cytokine or growth factor stimulation
(Stoker and Gherardi, 1991; Leavesley et al., 1993; P. Chen
et al., 1994; Klemke et al., 1994; Kundra et al., 1994; Ye-
nush et al., 1994). In fact, recent observations indicate that
inhibition of integrin-induced Ras activation of ERK2 did
not affect focal contact formation, cell adhesion, or actin
reorganization leading to cell spreading on fibronectin (Clark
and Hynes, 1996).
Previous studies have shown that MAP kinase activity is
critical for gene transcriptional events leading to cell pro-
liferation and differentiation. Evidence presented in this
report demonstrates that MLCK, a key regulator of cell
motility and contraction, is a substrate for MAP kinase.
This finding may explain how growth factors, cytokines, or
integrins that activate MAP kinases can thereby influence
cell movement on the extracellular matrix during tissue re-
modeling as well as tumor cell invasion.
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